Inventor · disambiguated record
Usha R. Patel
Also filed as: PATEL USHA · PATEL USHA R
24 granted patents·1 pending application·780 citations·filing 1985–2004
96Inventor score
Top patents by PatentIndex Score
25 records- 0198US6770639B2Heterocyclic compounds useful as inhibitors of tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Aug 3, 2004·205 cites·5 claims
- 0298US6506769B2Heterocyclic compounds useful as inhibitors of tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Jan 14, 2003·240 cites·32 claims
- 0391US6506747B1Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agentsBOEHRINGER INGELHEIM PHARMA·Filed 1999·Granted Jan 14, 2003·136 cites·15 claims
- 0488US6313117B1Succinate derivative compounds useful as cysteine protease inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Nov 6, 2001·39 cites·27 claims
- 0587US6660732B2Compounds useful as anti-inflammatory agentsBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Dec 9, 2003·24 cites·22 claims
- 0687US6525052B2Compounds useful as reversible inhibitors of cysteine proteasesBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Feb 25, 2003·17 cites·11 claims
- 0782US6858623B2Compounds useful as reversible inhibitors of cysteine proteasesBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Feb 22, 2005·9 cites·9 claims
- 0882US4833249AIsothiazolone 1,1-dioxide derivatives with psychotropic activityAMERICAN HOME PROD·Filed 1987·Granted May 23, 1989·16 cites·4 claims
- 0977US6268365B1Src family SH2 domain inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 1999·Granted Jul 31, 2001·31 cites·5 claims
- 1074US7019006B2Compounds useful as anti-inflammatory agentsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Mar 28, 2006·5 cites·17 claims
- 1173US6936606B2Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteasesBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Aug 30, 2005·7 cites·12 claims
- 1273US4766215AHistamine H1 -receptor antagonistsAMERICAN HOME PROD·Filed 1987·Granted Aug 23, 1988·9 cites·4 claims
- 1371US6787540B2Compounds useful as reversible inhibitors of cysteine proteasesBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Sep 7, 2004·2 cites·17 claims
- 1469US7026476B2Intermediate arylamine compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Apr 11, 2006·2 cites·2 claims
- 1565US6982263B2Nitriles useful as reversible inhibitors of cysteine proteasesBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Jan 3, 2006·2 cites·22 claims
- 1665US4855430APolycyclicamine with psychotropic activityAMERICAN HOME PROD·Filed 1987·Granted Aug 8, 1989·6 cites·4 claims
- 1763US8741897B2Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereofBEKKALI YOUNES·Filed 2004·Granted Jun 3, 2014·3 cites·3 claims
- 1862US4927934APolycyclicamine with psychotropic activityAMERICAN HOME PROD·Filed 1989·Granted May 22, 1990·5 cites·4 claims
- 1954US4672117AAntipsychotic gamma-carbolinesAMERICAN HOME PROD·Filed 1985·Granted Jun 9, 1987·6 cites·10 claims
- 2052US6054470ASrc family SH2 domain inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 1998·Granted Apr 25, 2000·7 cites·12 claims
- 2145US6284768B1Src family SH2 domain inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 1999·Granted Sep 4, 2001·4 cites·10 claims
- 2244US5837704A2-heteroaryl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-E! 1,4!diazepines and their use in the prevention or treatment of HIV infectionBOEHRINGER INGELHEIM PHARMA·Filed 1995·Granted Nov 17, 1998·3 cites·7 claims
- 2344US2001041700A1Novel succinate derivative compounds useful as cysteine protease inhibitorsFiled 2001·Application pending·0 cites
- 2442US4937347APolycyclicamine with psychotropic activityAMERICAN HOME PROD·Filed 1989·Granted Jun 26, 1990·1 cites·4 claims
- 2541US4942234AIsothiazolone 1,1-dioxide derivatives with psychotropic activityAMERICAN HOME PROD·Filed 1989·Granted Jul 17, 1990·1 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Usha R. Patel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →